JPS60193468A - Leucocyte removal filter - Google Patents

Leucocyte removal filter

Info

Publication number
JPS60193468A
JPS60193468A JP59048173A JP4817384A JPS60193468A JP S60193468 A JPS60193468 A JP S60193468A JP 59048173 A JP59048173 A JP 59048173A JP 4817384 A JP4817384 A JP 4817384A JP S60193468 A JPS60193468 A JP S60193468A
Authority
JP
Japan
Prior art keywords
blood
fibers
leukocyte removal
filter
blood cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59048173A
Other languages
Japanese (ja)
Other versions
JPH0213587B2 (en
Inventor
渡辺 廣行
陸丸 紘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Medical Co Ltd filed Critical Asahi Medical Co Ltd
Priority to JP59048173A priority Critical patent/JPS60193468A/en
Priority to US06711667 priority patent/US4701267B1/en
Priority to EP85102975A priority patent/EP0155003B1/en
Priority to DE8585102975T priority patent/DE3578502D1/en
Publication of JPS60193468A publication Critical patent/JPS60193468A/en
Publication of JPH0213587B2 publication Critical patent/JPH0213587B2/ja
Priority to JP3135364A priority patent/JPH0651063B2/en
Granted legal-status Critical Current

Links

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 本発明は、血液、体液等の血球浮遊液から白血球を選択
的に除去するためのフィルターに関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a filter for selectively removing white blood cells from a blood cell suspension such as blood or body fluid.

近年、血液学、免疫学の発達によシ、従来の全血輸血に
代わって、患者が必要とする血液の成分だけを与え、不
要な成分は極力与えない成分輸血が注目金うびている。
In recent years, due to the development of hematology and immunology, component transfusion has been gaining attention as an alternative to conventional whole blood transfusion, in which only the blood components required by the patient are given, and unnecessary components are not given as much as possible.

成分補血には、赤血球輸血、白血球補血、血小板輸血、
血漿輸血などがあり、貧血、心臓および肺疾患の患者等
に赤血球のみを輸注する症例は極めて多い。その理由と
して、全血、赤血球濃厚液を輸血された患者が、悪感、
発熱、頭痛、吐き気などの副作用を示すことが報告され
ている。これらの原因は、輸注される血液中の白血球が
有しているHLA抗原、ないしは組織抗原と呼ばれる抗
原と受血者の抗体との免疫反応、すなわち、抗日血球抗
体産生によるものと言われるbしたがって、赤血球輸血
の場合には、白血球、血小板等、抗原となる物質をでき
るだけ除去した赤血球濃厚液を輸注することが望ましい
Blood component replacement includes red blood cell transfusion, white blood cell transfusion, platelet transfusion,
There are many cases where only red blood cells are transfused to patients with anemia, heart or lung disease, etc., such as plasma transfusion. The reason for this is that patients who receive transfusions of whole blood or concentrated red blood cells experience nausea,
It has been reported that side effects include fever, headache, and nausea. The cause of these is said to be an immune reaction between the HLA antigens or tissue antigens possessed by the white blood cells in the transfused blood and the recipient's antibodies, that is, the production of anti-Japanese blood cell antibodies. In the case of red blood cell transfusion, it is desirable to inject a concentrated red blood cell solution from which antigenic substances such as white blood cells and platelets have been removed as much as possible.

これらの知見より、現在、白血球、血小板全できるだけ
除去した濃厚赤血球を得る方法が種々検討されている。
Based on these findings, various methods of obtaining concentrated red blood cells from which all white blood cells and platelets have been removed are currently being investigated.

この方法は、大別すると3通9ある。一つには、遠心分
離により白血球、血小板、血漿を4分離し、濃軸戯焙得
る方法、二つには、全血にデキストランを加え、白血球
が付着したデキストランを除去し、さらに、生理的食塩
水でデキストランを洗浄除去し、濃厚赤血球を得る方法
、三つには、繊維全適当に充填したフィルターで白血球
全捕捉し、白血球除去濃厚赤血球を得る方法でるる。
Broadly speaking, there are 3 types of this method: 9. One method is to separate white blood cells, platelets, and plasma into four parts by centrifugation and obtain concentrated blood. The second method is to add dextran to whole blood, remove the dextran to which white blood cells are attached, and then add physiological The third method is to wash away the dextran with saline to obtain concentrated red blood cells, and the third method is to capture all white blood cells with a filter filled with fibers appropriately to obtain concentrated red blood cells from which leukocytes have been removed.

しかしながら、遠心分離法は、その装置が高価であるこ
と、白血球および血小板を90%程度除去するためには
、生理食塩水での洗浄を6回以上くシ返さなければなら
ないこと、白血球を吸引せずに、分シWした赤血球を吸
引して分離するため、赤血球の20係程度は無駄となる
ことに問題があるが、デキストラン沈降法も白血球除去
率を90%程度にするには、6回以上の生理食塩水の洗
浄とデキストランの洗浄が必要であり、時間がかかり、
操作性も難儀である。
However, centrifugation requires expensive equipment, requires repeated washing with physiological saline six or more times to remove approximately 90% of white blood cells and platelets, and requires suction of white blood cells. There is a problem in that about 20 cells of red blood cells are wasted because the separated red blood cells are aspirated and separated without removing the cells, but the dextran sedimentation method also requires 6 times to achieve a leukocyte removal rate of about 90%. The above saline washing and dextran washing are necessary and time consuming.
Operability is also difficult.

繊維分充填したフィルター装置で白血球を捕捉、除去し
、白血球のない赤血球に富んだ赤血球製剤を得るための
方法としては、特公昭5B−54125号および特公昭
58−54.126号が必るが、これらの発明は、血液
全変性させない合成繊維、半合成繊維、再生人造繊維、
無機繊維、天然繊維の少なくとも1種が、カラムにo、
1sr/7以下の密度で詰められた白血球分離フィルタ
ー装置、および平均直径が10μm以下の血液を変性さ
せない合成繊維、半合成繊維、再生人造繊維、無機繊維
または天然繊維からなる白血球分離材というものであシ
、血液からfiij単な操作で純度、収率良く白血球を
捕捉、除去できるという%徴があるが、実際に病院で使
用する大きさのフィルターでは、処理速度が571 /
 mm程度であり、20〇−処理するのに約40分、5
007処理するのに100分程度かかり、処理時間とし
て長くかかりすぎるという問題、丑た、この間、血液を
室温放置すれば、血液の変性が進むという問題、さらに
は、処理速度を上げるには極端にフィルターの容量が犬
きくなシ、一定の大きさで繊維を0.i 5 ii’ 
/m以上詰めると、赤血球まで捕捉するため目詰りし、
極端に処理速度が減少するという問題がめった。
Japanese Patent Publication No. 5B-54125 and No. 58-54.126 are necessary for obtaining a red blood cell preparation rich in red blood cells without white blood cells by trapping and removing white blood cells using a filter device filled with fibers. , these inventions include synthetic fibers, semi-synthetic fibers, regenerated artificial fibers,
At least one of inorganic fibers and natural fibers is present in the column.
A leukocyte separation filter device packed at a density of 1 sr/7 or less, and a leukocyte separation material made of synthetic fibers, semi-synthetic fibers, recycled artificial fibers, inorganic fibers, or natural fibers that do not denature blood and have an average diameter of 10 μm or less. It is said that leukocytes can be captured and removed from blood with a simple operation in high purity and high yield, but in reality, with a filter of the size used in hospitals, the processing speed is 571 /
It is about 200 mm, and it takes about 40 minutes to process, 5
007 It takes about 100 minutes to process, which is too long as a processing time. Also, if the blood is left at room temperature during this time, the denaturation of the blood will proceed. The capacity of the filter is small, so it is possible to remove fibers of a certain size by 0. i 5 ii'
If it is packed more than /m, it will become clogged because even red blood cells will be captured.
The problem was that the processing speed decreased drastically.

本発明者らは、多量の血液からrt+i単な操作で、純
度、収率よ<、シかも、ごく短時間の処理で白血球を分
離除去する方法について鋭怠検討した結果、直径が6μ
m未満の繊維で形成され、嵩密駄がo、tsy/7を超
え0.507 /dの範囲に必る不織布が、従来のもの
に比較して、繊維層を薄くすること、およびフィルター
の圧損金小さくすることができ、その結果、処理時間が
10分の1くらいと大巾に短縮されて、しかも、純度、
収率よく白血球を分離除去できることを見出した。この
際、上記の不織布は、繊維の互いのもつれによりその位
置に固定されているものであることが好ましい。
The present inventors have painstakingly investigated a method for separating and removing white blood cells from a large amount of blood in a very short time with a simple rt+i operation, and found that white blood cells with a diameter of 6μ
A nonwoven fabric made of fibers of less than Pressure loss can be reduced, and as a result, processing time can be drastically shortened to about one-tenth, and purity and purity can be reduced.
It has been found that leukocytes can be separated and removed with good yield. In this case, it is preferable that the above-mentioned nonwoven fabric is fixed in position by mutual entanglement of fibers.

本発明によれば、tIl、維径が極端に細い繊維からな
る不織布全使用することにより、フィルターは牙も高に
なると共て、フィルター装置の縦方向および横方向に対
して、繊維を均密に充填することができる。さらには、
1細い繊fffk均密に充填できるため、細い繊維では
考えられないほど充填密度を上げることが可能である。
According to the present invention, by fully using a nonwoven fabric made of fibers with an extremely small fiber diameter, the filter has high fangs and the fibers are evenly distributed in the vertical and horizontal directions of the filter device. can be filled. Furthermore,
1 Thin fiberfffk can be packed evenly, so it is possible to increase the packing density to an extent that would be unimaginable with thin fibers.

そのため、血液との接触面積を大きくすると共に、白血
球除去に必要な縦方向の長さを著しく短かくすることが
できる。
Therefore, the contact area with blood can be increased, and the length in the vertical direction required for removing leukocytes can be significantly shortened.

したがって−1血液を流した場合のフィルターの圧損が
少なく、処理速度が速くなり、短時間処理ができるもの
である。
Therefore, when -1 blood is passed through the filter, the pressure loss in the filter is small, the processing speed is increased, and processing can be performed in a short time.

また、が山径繊維の不織布にすることにより、繊維間隙
が一定かつ均密で、繊維1ffl隙を小さくすることが
でき、血液のチャンネリングが防止でき、白血球の除去
性能が向上、さらには、製品間のノくラツキも減少する
ことになる。そして、製品の厚さを薄く、小型化が可能
であるから、プライミングボリュームを小さくシ、赤血
球の回収率が向上する効果がある。また、処理速度が速
く、操作時間が短かいことは、4C保存の血e、を室温
で処理する場合、血液温度の上昇全防ぐことができ、血
液の変性等にも効果がある。さらに、不織布にすること
により、処理時に出る糸くずがなく々す、輸血時の糸く
ずの混入が防止できるという効果もある。
In addition, by using a nonwoven fabric made of threaded fibers, the fiber gaps are constant and uniform, the fiber 1ffl gap can be reduced, blood channeling can be prevented, and leukocyte removal performance is improved. The unevenness between products will also be reduced. Furthermore, since the product can be made thinner and more compact, the priming volume can be reduced and the recovery rate of red blood cells can be improved. In addition, the high processing speed and short operation time can prevent any rise in blood temperature when blood stored at 4C is processed at room temperature, and is also effective against blood denaturation. Furthermore, by using a non-woven fabric, it is possible to eliminate lint produced during treatment and prevent lint from being mixed in during blood transfusion.

本発明において使用する繊維は、血液全変性させない合
成繊維であり、ポリアミド、芳香族ポリアミド、ポリエ
ステル、ポリアクリロニトリル系、ポリトリフルオロク
ロルエチレン、ポリメチルメクアクリレート、ポリスチ
レン、ポリエチレンポリプロピレンなどがある。そして
、直径が6μm以下の繊維全作るには、一般的には9、
ILシいが、直径が3μm以下の繊ak作る方法として
は、浴融ブロー法(melt−blowing pro
cess )があり、この方法により、本発明の直径が
5μm以下の繊維全作成した。しかし、本発明に使用す
る6μm以下の繊維は、この方法に限定されるものでは
ない。
The fibers used in the present invention are synthetic fibers that do not cause total blood denaturation, and include polyamide, aromatic polyamide, polyester, polyacrylonitrile, polytrifluorochloroethylene, polymethylmequaacrylate, polystyrene, polyethylene polypropylene, and the like. To make all the fibers with a diameter of 6 μm or less, generally 9,
The method for producing IL fibers with a diameter of 3 μm or less is the melt-blowing method.
cess), and all fibers of the present invention having a diameter of 5 μm or less were prepared by this method. However, the fibers of 6 μm or less used in the present invention are not limited to this method.

木兄Φ」の不織布は、繊維が繊維の互いのもつれにより
その位11グに固定されているものであることが好1し
く、このような不織布とするための繊維間の固定法とし
ては、こり、らのf或維の融点隋近の熱全加えて熱固治
させたり、接着剤による固定法が必p、これらは勿論、
本発明に使用できるが、本発明で用いる繊維のように繊
維が細くなると、エアーブロー法、高圧蒸気ブロー法な
どにより、繊維全圧いにもつれさせるだけで繊維間が固
定きすし、このように作成した不織布は、例えば、(l
!!:壊するような大きな力?加えない限り安定であり
、血液処理にも充分耐えることができる。したがって、
このように児俄に固渚烙せないエアーブロー法、高圧蒸
気ブロー法などによる単に繊維を互いにもつれさせるだ
けの繊維の固定法も採用できる。
It is preferable that the non-woven fabric of "KIENΦ" is one in which the fibers are fixed in such a way that they are entangled with each other, and the method of fixing the fibers to make such a non-woven fabric is as follows: Of course, it is necessary to apply heat close to the melting point of the fiber or to cure it by heat, or to fix it with an adhesive.
Although it can be used in the present invention, when the fibers are thin like the fibers used in the present invention, the fibers can be fixed by simply entangling the fibers under total pressure using an air blow method, high pressure steam blow method, etc. The created nonwoven fabric is, for example, (l
! ! : A huge force that could destroy it? It is stable unless added, and can withstand blood treatment well. therefore,
In this way, it is also possible to adopt a method of fixing the fibers by simply entangling the fibers with each other, such as an air blowing method or a high-pressure steam blowing method, which does not cause the fibers to be heated too quickly.

本発明の不織布全構成する繊維の直径は3μm未満であ
り、好葦しくは0.1μmから3μm未満、さらに好1
しくは0.1μmから2.0μmの範囲である。繊維の
直径が0.1μmより小さい場合は、実際には作成が難
しいが、高嵩になりすさ゛、均密に充填すると、繊維間
隙が極小になり、白血球と共に赤血球も捕捉することに
なシ、目詰りを生じ、処理速度が極端に減少してし1つ
ことになる。繊維の直径が3μm以上の場合は、充填密
朋を上けて、繊維間隙奮小ざくすることが必要でらり、
例えば、直径が3μm以上の繊維では a、s o y
 1crdを超える充填密度にしないと白血球の除去率
が低下してしまうことになる。さらには、充填密度が旨
いため、高圧下で充填することになり、繊維の破壊が生
じてし1うことになる。まlこ、一定容積での血液接触
が小さいため、白血球除去フィルターの谷状が著しく犬
きくなってし寸い、病院では取扱いが難かしい。
The diameter of the fibers constituting the entire nonwoven fabric of the present invention is less than 3 μm, preferably from 0.1 μm to less than 3 μm, and more preferably from 0.1 μm to less than 3 μm.
Preferably, it is in the range of 0.1 μm to 2.0 μm. If the diameter of the fibers is smaller than 0.1 μm, it is actually difficult to make, but it tends to be bulky.If the fibers are packed evenly, the gaps between the fibers will be extremely small, and red blood cells will be captured along with white blood cells. This results in clogging and extremely reduced processing speed. If the diameter of the fibers is 3 μm or more, it is necessary to increase the packing density and reduce the fiber gaps.
For example, for fibers with a diameter of 3 μm or more, a, so y
Unless the packing density exceeds 1 crd, the leukocyte removal rate will decrease. Furthermore, since the packing density is high, the packing must be carried out under high pressure, which will prevent the fibers from breaking. However, because the contact with blood in a given volume is small, the valley shape of the leukocyte removal filter becomes extremely sharp, making it difficult to handle in hospitals.

本発明の不織布の密度は、o、1s7/7ケ超え0.5
0 f /cdの範囲にあることが必要であシ、好まし
くは0.20 f /crdからLl、60 p /d
の範囲である。不織布の密度がo、is!i′/7より
小さい場合は、例えば、50mel−という短時間処理
になると白血球が?、”; ;/1.てくる。丑た、不
織布の密度が0.50j//〜より大きくなると、裁、
イを間隙が、斂密になって、赤血球も捕捉されるように
なシ、赤血球の回収率が低ドしてくる。
The density of the nonwoven fabric of the present invention is o, 1s7/7 and 0.5
It should be in the range of 0 f /cd, preferably 0.20 f /crd to Ll, 60 p /d
is within the range of The density of the nonwoven fabric is o, is! If it is smaller than i'/7, for example, when treated for a short time of 50 mel-, white blood cells will increase. , ”; ;/1. When the density of the nonwoven fabric becomes larger than 0.50j//, the cutting,
As the gaps become denser and red blood cells are also trapped, the recovery rate of red blood cells decreases.

本発明の不織布の厚さは、血液や血球浮遊液の短時間処
理のためには111i11から301fll!l、好ま
しくは1111111から20 b+lll %さらに
好ましくは2141111から1 o rr+rn o
範囲である。不織布の厚さがI Mmより薄くなると、
白血球の捕捉が十分ではなく、白血球の捕捉率が低下し
てくる。寸た、不織布の厚さが50 mrnより厚くな
ると、圧損が大きくなり、処理速度が低下してくる。
The thickness of the nonwoven fabric of the present invention ranges from 111i11 to 301fl for short-time treatment of blood and blood cell suspensions! l, preferably 1111111 to 20 b+lll %, more preferably 2141111 to 1 o rr+rn o
range. When the thickness of the nonwoven fabric becomes thinner than I Mm,
The capture of leukocytes is not sufficient, and the capture rate of leukocytes decreases. On the other hand, if the thickness of the nonwoven fabric is greater than 50 mrn, the pressure loss will increase and the processing speed will decrease.

本発明のフィルター面積は、血液や血球浮遊液の短時間
処理のためには、繊維1爛の間隙部を含めた血液人口1
則のh泡面積が1ocrtl/血戚500艷から200
0Cd/血7y s o o)nl、好ましくは20(
ゴ/血液s o o meから1ooOd/血7f 5
00 rnl。
In order to process blood and blood cell suspension in a short period of time, the filter area of the present invention is determined by the blood population 1 including the gap between fibers 1 and 1.
The rule is that the bubble area is 1ocrtl/blood relatives 500 to 200
0Cd/blood7ys o o)nl, preferably 20(
Go/Blood so o me to 1ooOd/Blood 7f 5
00rnl.

さらに好ましくは3Dば/血液500m1から300d
/血液500−の範囲である。フィルター面積が10c
rl/血液s o o meより小さいと、白血球除去
フィルターの表面が白血球で飽和されてくるため、処理
速度が遅くなってくる。また、フィルター面積が200
OC11/血液500 mlより太きb場合は、白血球
除去処理後の白血球除去フィルター内の赤血球回収のた
めの生理&′虐水が多部にヅ・要であり、かつ白血球除
去フィルター内に残る赤血球も多くなるため、赤血球の
回収率が低下してくる。
More preferably 3D blood/500ml to 300d
/Blood 500-. Filter area is 10c
When it is smaller than rl/blood so o me, the surface of the leukocyte removal filter becomes saturated with leukocytes, resulting in a slow processing speed. Also, the filter area is 200
OC11/If the blood size is larger than 500 ml, it is necessary to use a lot of menstrual water to collect red blood cells in the leukocyte removal filter after leukocyte removal treatment, and red blood cells remaining in the leukocyte removal filter. Since the number of red blood cells increases, the recovery rate of red blood cells decreases.

なお、本発明の不織布の嵩密度とは、均一な不織布17
当りの、その重ざ忙6111疋した値全訂う。
Note that the bulk density of the nonwoven fabric of the present invention refers to the uniform nonwoven fabric 17
The value of that heavy 6111 hiki is completely revised.

本発明の目的とする多量の血液から簡単な操作で収率よ
<、シかも、ごく短1jイ間の処理で白血球を捕捉除去
するにCま、繊維の直往が6μm未774で、嵩密度が
0.157 /d7..11.−0.50 f 1Cu
NJ下)不誠イFからなるフィルターであるこ々が必要
であり、好丑しくは不織布が繊維の互いのもつれにより
その位置に固定δ北ているものであって、避らには、不
織布の密度、厚さ、およ0.フィルター四積が前記の範
囲にあることである。
It is possible to obtain a high yield with a simple operation from a large amount of blood, which is the object of the present invention. The density is 0.157/d7. .. 11. -0.50 f 1Cu
NJ (lower part) A filter consisting of unscrupulous F is necessary, preferably a non-woven fabric fixed in position by the mutual entanglement of the fibers; Density, thickness, and 0. The filter quadriproduct is within the above range.

以下、図面によって本発明の白血球除去フィルターおよ
び該フィルターによるフィルター装置の詳細を説1男す
る。
Hereinafter, details of the leukocyte removal filter of the present invention and a filter device using the filter will be explained with reference to the drawings.

第1図および第2図は、本発明の白血球除去フィルター
によるフィルター装置の一実施態様を示し、第3図およ
び第4図は、別の実施弗椋を示すものである。第1図お
よび第2図において、1はフィルター装置本体で、二つ
の丸盆状枠体2,2′が望胴部全形成するように、リン
グ部材6で嵌合し、丸盆状枠体2,2′の内面には、そ
れぞれ多数の突条4,4′が形成され、その内側に、メ
ソシュ状支持材5,5′に挾1れて、不織布からなるフ
ィルター6が設けられている。7は一方の丸盆状枠体2
に設けられた血液流入管、8は他方の丸盆状枠体2′に
設けられた血液流出冒であり、9.9’はバッキングで
ある。そして、フィルター6はメソシュ状支持材5,5
′によって、密度がJl 5 f、/iを超え0.50
2/d以下の範囲に保持されている。
1 and 2 show one embodiment of a filter device using a leukocyte removal filter of the present invention, and FIGS. 3 and 4 show another implementation. In FIGS. 1 and 2, 1 is a filter device main body, and two round tray-shaped frames 2 and 2' are fitted together with a ring member 6 so that the entire desired body is formed. A large number of protrusions 4, 4' are formed on the inner surfaces of the protrusions 2, 2', respectively, and a filter 6 made of a non-woven fabric is provided inside the protrusions 4, 4' sandwiched between mesh-like supports 5, 5'. . 7 is one round tray-shaped frame body 2
8 is a blood outflow pipe provided in the other round tray-shaped frame 2', and 9.9' is a backing. The filter 6 is made up of mesoche-like support materials 5, 5.
', the density exceeds Jl 5 f,/i by 0.50
It is maintained within a range of 2/d or less.

第6図および第4図のフィルター装置も、前記フィルタ
ー装置とはy同様であるが、血液流入管16および血液
流出管14が丸盆状枠体10 、10’のそれぞれ中心
部に設けられ、空胴部には、メツシュ状支持材11 、
11’に挾1れて、不織布からなるフィルター12が設
けられている。i 5 、15’はバンキングである。
The filter devices shown in FIGS. 6 and 4 are similar to the filter device described above, but a blood inflow pipe 16 and a blood outflow pipe 14 are provided at the center of the round tray-shaped frames 10 and 10', respectively. In the cavity, a mesh-like support material 11,
A filter 12 made of non-woven fabric is provided between 11'. i 5 , 15' is banking.

メツシュ状支持材は、血液の流体が均一流になるように
メツシュ状にしており、流路規制部の役割もしている。
The mesh-like support material is shaped like a mesh so that the blood fluid flows uniformly, and also serves as a flow path regulating section.

血液は血液流入管7あるlAは16よシ導入され、メツ
シュ状支持材5あるbは11ヲ進過することにより、均
一流となり、次にフィルター6あるいは12に導入され
、白血球および血小板等が捕捉され、赤血球および血漿
が通過し、白血球除去濃厚赤血球となった皿り、は、メ
ツシュ状支持材5′あるbは11′全通過することによ
り、さらに均一流となシ、血液流出管8あるいは14か
ら回収されることになる。
The blood is introduced through the blood inflow tube 7, 16, and passes through the mesh-like support 5, 11, resulting in a uniform flow.The blood is then introduced into the filter 6 or 12, where white blood cells, platelets, etc. The collected red blood cells and plasma pass through the dish, which becomes leukocyte-removed concentrated red blood cells, and the mesh-like support member 5' and b 11' pass through the entire dish, resulting in a more uniform flow. Or it will be collected from 14th.

上記フィルターは、繊維表面の粘着性、荷電性、疎水性
および繊維間隙などにより、血液中の白血球、血小板等
を選択的に捕捉し、赤血球、血漿のみ全通過させるもの
で、繊維表面の粘着性、荷電性、疎水性の効果は、繊維
間隙に大きく影響される。1だ、上記フィルターは、直
径5 ltm未満の繊維からなり、不織布としての形状
は、綿状、布状、IR維状をしている。該不織イ15は
、繊維が熱溶着等により円建き九た不織布であると、繊
維間隙が固定され、均密になることが可能であり、直径
3μm未満の繊維のみを充填した白血球除去フィルター
装置11、ないしは直径5μm未満で単なる不織イ[全
光埴した白血球除去フィルター装置に比較して、より一
層、血液のチャンオリング防止、白血球および血小板の
除去性能の向上、操作時間の減少および糸クズ等ゴミの
混入の防止に効果がある。
The above filter selectively captures white blood cells, platelets, etc. in blood due to the adhesiveness, chargeability, hydrophobicity, and fiber gaps of the fiber surface, and allows only red blood cells and plasma to pass through. The effects of , chargeability, and hydrophobicity are greatly influenced by the fiber gap. 1. The above filter is made of fibers with a diameter of less than 5 ltm, and the shape of the nonwoven fabric is cotton-like, cloth-like, or IR fiber-like. The non-woven fabric 15 is a non-woven fabric in which the fibers are circularly formed by thermal welding or the like, so that the gaps between the fibers are fixed and can be made uniform. The filter device 11 is a simple non-woven filter with a diameter of less than 5 μm [Compared to a full-scale leukocyte removal filter device, it is more effective in preventing blood chorion, improving leukocyte and platelet removal performance, reducing operation time, and It is effective in preventing dirt such as lint from getting mixed in.

さらに、白血球、血小板等の捕捉性および赤血球、血漿
の通過性は、不織布の嵩密度にj)1係する。
Furthermore, the ability to capture white blood cells, platelets, etc. and the permeability of red blood cells and plasma are dependent on the bulk density of the nonwoven fabric.

健康人の全血、P RCu、および牛の全血、P RC
成金使用した詳バ用な試J倹結果によ才しば、不織イ「
の嵩密度は、0.159 /Cdを超えり、50y/c
m以下が適し、ポリエステル糸からなる不織布の高密I
fは0.30 ? /c+cl呈度が好ましい。
Healthy human whole blood, P RCu, and bovine whole blood, P RC
Based on the results of the exam for the detailed bar using the money, it will be better if the results are good.
The bulk density of is greater than 0.159/Cd and 50y/c
m or less is suitable, high density I of nonwoven fabric made of polyester thread
Is f 0.30? /c+cl presentation degree is preferred.

rAE ”図は、本発す]の白血球除去フィルターによ
るフィルター装置の一使用態様を示すものである。
rAE" The figure shows one mode of use of the filter device using the leukocyte removal filter of the present invention.

人体から採集された血液は、採血バッグ16から落差圧
により、回路171.3) :I(1+す、不発明の白
血球除去フィルターによるフィルター装置18に供給さ
れる。フィルター装置18に導入された血液は、フィル
ター装置の不織布よりなる白血球除去フィルターにより
、白血球、血小板等が捕捉され、赤血球、血漿が主とな
る血液となり、回路19を通過後、回収バッグ20に供
に6される。赤血球の回収4全より高める場合は、あら
かじめ用意した生理食塩水バッグ21より、同様にして
、回路22全通してフィルター装置18に導入し、回路
および白血球除去フィルターに−tXV、残存している
赤血球7、より以上に回収できる。なお、23は回収バ
ッグ、24は調整バルブである。
The blood collected from the human body is supplied from the blood collection bag 16 by the differential pressure to the filter device 18 using a leukocyte removal filter of the present invention.The blood introduced into the filter device 18 In this case, white blood cells, platelets, etc. are captured by the white blood cell removal filter made of non-woven fabric of the filter device, and the blood mainly consists of red blood cells and plasma.After passing through the circuit 19, it is sent to the collection bag 20.Recovery of the red blood cells. 4. If you want to increase the concentration more than 4, introduce the saline bag 21 prepared in advance into the filter device 18 through the entire circuit 22, and add -tXV, remaining red blood cells 7, and more to the circuit and leukocyte removal filter. In addition, 23 is a collection bag, and 24 is an adjustment valve.

以上は、人体から採取された血液が採血バッグに入って
いる例を示したが、[α接、人体より血液全採取し、循
環ポンプ等により、フィルター装置に導入し、白血球等
を除去した赤血球、血漿が主となる血液を再び体内にも
どすこともできる。
The above example shows blood collected from a human body contained in a blood collection bag. It is also possible to return blood, mainly plasma, back into the body.

以上述べたように、本発明による白血球除去フィルター
は、血液、血球浮遊液から簡単な操作で、収率よ<、シ
かも、ごく短時間の処理で、白血球を分離、除去で、き
るものである。
As described above, the leukocyte removal filter according to the present invention can separate and remove leukocytes from blood or a blood cell suspension in a very short period of time with simple operations and a low yield. be.

以下、実施例を挙げて説明する。Examples will be described below.

実施例1 直径1.2μmのポリエステル繊維全溶融ブロー法で作
成した嵩密度Jl 8 f/cn′lの繊維塊が繊維の
互いのもつれによってその位置に固定されている不織有
金、直径110111111.厚さ7 Tnmの円柱状
に切断し、有効内径1001111a (有効内径=血
液または血球浮遊液が実際にフィルター表面に接触する
部分の径を示す。以後の実施例においても同じ)、厚さ
11朋のカラム中に固定した。600−の採血バッグ2
個からそれぞれ落差800+11111の位置に、上記
の白血球除去フィルター装置をつけ、さらにaoomm
T方に1tの輸液バッグをつけて、処理【またtLを貯
蔵する回収バッグとし、その間をそれぞれ内径5111
a 、外径5鶴のチューブで連結した処理装置t作成し
た。この処理装置の採血バッグ2個に、A型の健康人の
へマドクリット38%の新鮮CPD液添加血液全血25
0 mlずつを入れ、落差を利用した自然落下法により
、室温25Cで1バツグずつ順番に白血球除去処理を行
った。
Example 1 Polyester fibers with a diameter of 1.2 μm A non-woven metal fabric with a bulk density Jl 8 f/cn′l fabricated by the total melt blowing method and fixed in position by mutual entanglement of the fibers, diameter 110111111 .. Cut into a cylindrical shape with a thickness of 7 Tnm, an effective inner diameter of 1001111a (effective inner diameter = diameter of the part where blood or blood cell suspension actually contacts the filter surface. The same applies to subsequent examples), and a thickness of 11 mm. was fixed in a column. 600- blood collection bag 2
Attach the above leukocyte removal filter device at a height of 800 + 11111 from each individual, and add the aoomm
Attach a 1 ton infusion bag to the T side for processing [and a collection bag for storing t L, and a bag with an inner diameter of 5111 mm between each.
A. A processing device T connected with tubes having an outer diameter of 5 mm was prepared. Two blood collection bags of this processing device contain 25 liters of fresh CPD solution-added whole blood with a hemadcrit of 38% from a healthy person with type A blood.
0 ml each was added, and leukocyte removal treatment was performed one bag at a time at a room temperature of 25C using a gravity drop method using a drop.

つぎに、生理食塩水90m1f自然落下法により、この
白血球除去フィルター装置に流し、フィルター内の赤血
球を回収した。
Next, 90 ml of physiological saline was poured into this leukocyte removal filter device by a gravity drop method, and the red blood cells in the filter were collected.

その結果、この新鮮血液500−の処理時間は6分35
秒であり、処理速度にして76−7分という高流速であ
った。また、白血球除去率は?9.7チであり、赤血球
回収率は95%であった。
As a result, the processing time for this fresh blood 500- is 6 minutes 35 minutes.
It was a high flow rate of 76-7 minutes in terms of processing speed. Also, what is the leukocyte removal rate? The red blood cell recovery rate was 9.7%, and the red blood cell recovery rate was 95%.

比較例1 直径が9.6μm、長さが40 l1juから7011
1111のポリエステル繊維を、直径が5011111
1 、長さ’00mrn(r)カラムに92を均一に詰
めた白血球除去フィルター装置(嵩密度o、1s y 
/crd )を作成した。300ゴの採血バッグ2個か
らそれぞれ@差a o o mmの位置に、上記の白血
球除去フィルター装置をつけ、さらに80011III
+下方に1tの輸液バッグ金つけて、処理した血液を貯
蔵する回収バッグきし、その間をそれぞれ内径3111
15 、外径51四のチューブで連結した処理装置全作
成した。この処理装置の採血バッグ2個に、A型の健康
人のへマドクリット38チの新鮮CPD液添加血液全血
250−ずつを入れ、落差を利用した自然落下法によシ
、室温25Uで1バツグずつ順番に白血球除去処理を行
った。
Comparative Example 1 Diameter is 9.6 μm, length is 40 l1ju to 7011
1111 polyester fiber with a diameter of 5011111
1. Leukocyte removal filter device (bulk density o, 1s y
/crd) was created. Attach the leukocyte removal filter device described above at a distance of a o o mm from each of the two 300 g blood collection bags, and then add the 80011 III blood collection bag.
+ A 1 ton infusion bag is attached below, and a collection bag for storing the processed blood is placed between them, each with an inner diameter of 3111 mm.
15, a complete processing apparatus connected with tubes having an outer diameter of 514 mm was prepared. Into two blood collection bags of this processing device, put 250 g of fresh CPD solution-added whole blood of 38 hematocrits of a healthy person with blood type A, and collect one bag at room temperature of 25 U using the natural fall method using the drop. Leukocyte removal treatment was performed on each sample in turn.

つぎに、生理食塩水80−ケ自然落下法により、この白
血球除去フィルター装置に流し、フィルター内の赤血球
を回収した。
Next, 80 g of physiological saline was poured into this leukocyte removal filter device by a gravity drop method, and the red blood cells in the filter were collected.

その結果、この新鮮血液500m7!の処理時間は1時
間52分35秒であり、処理速度にして5.4−7分で
あった。また、白血球除去率は93.2へ赤血球回収率
は96嗟であった。
As a result, this fresh blood amounted to 500m7! The processing time was 1 hour, 52 minutes, and 35 seconds, and the processing speed was 5.4-7 minutes. Furthermore, the leukocyte removal rate was 93.2 and the red blood cell recovery rate was 96.

実施例1によれば、本発明の白血球除去フィルターは、
従来の白血球除去フィルターと比較して約14倍の高速
処理であり、白血球除去率が良く、赤血球回収率も従来
法と同程度の優秀な性能であった。
According to Example 1, the leukocyte removal filter of the present invention includes:
Compared to conventional leukocyte removal filters, the processing speed was about 14 times faster, the leukocyte removal rate was good, and the red blood cell recovery rate was excellent, comparable to the conventional method.

実施例2 直径1.8μmのポリエステル繊維を溶融ブロー法で作
成した嵩密度0.22 ? /artの繊維塊が繊維の
互いのもつれによってその位置に固定されている不織布
を、直径78mm、厚さ411+1nの円柱状に切断し
、有効内径6am+j、厚さ8 m+aのカラ人中に固
定した。500 meの採血バッグ2個からそれぞれ落
差800 mThの位置に、上記の白血球除去フィルタ
ー装置をつけ、さらに8001nn下方に1tのrl扁
液バッグ分つけて、処理した液を貯蔵する回収バッグと
し、その間をそれぞれ内径311111 、外径511
111のチューブで連結した処理装置を作成した。この
処理装置の採血バッグ2個に、Bqの健康人のへマドク
リット42チの新鮮ACD−A液添加血油添加血液全血
0 meずつを入れ、落差全利用した自然落下法によシ
、室温25tl’で1バツグずつ順番に白血球除去処理
を行った。
Example 2 Polyester fibers with a diameter of 1.8 μm were made by melt blowing and had a bulk density of 0.22? A nonwoven fabric in which the fiber mass of /art was fixed in its position by the mutual entanglement of the fibers was cut into a columnar shape with a diameter of 78 mm and a thickness of 411 + 1 nm, and was fixed in a cylindrical shape with an effective inner diameter of 6 am + j and a thickness of 8 m + a. . The above-mentioned leukocyte removal filter device was attached to a position with a head height of 800 mTh from two 500 me blood collection bags, and a 1 ton RL fluid bag was attached below 8001 nn to serve as a collection bag for storing the processed fluid. The inner diameter is 311111 and the outer diameter is 511, respectively.
A processing device connected with 111 tubes was created. Into two blood collection bags of this processing device, 42 grams of fresh ACD-A fluid-added blood, oil-added whole blood, and 0 me of whole blood from a healthy human being of Bq were added, and the blood was collected by gravity using the full head at room temperature. Leukocyte removal treatment was performed one bag at a time at 25 tl'.

つぎに、生理食塩水40meを自然桁下法によシ、白血
球除去フィルター装置に流し、フィルター内の赤血球を
回収した。
Next, 40 me of physiological saline was poured into the leukocyte removal filter device using the natural submergence method, and the red blood cells in the filter were collected.

その結果、この新鮮血液500−の処理時間は7分15
秒であり、処理速度にして69m11分という高流速で
あった。また、白血球除去率100係、赤血球回収率は
98チであった。
As a result, the processing time for this fresh blood 500- is 7 minutes 15 minutes.
It was a high flow rate of 69 ml and 11 minutes in terms of processing speed. In addition, the leukocyte removal rate was 100% and the red blood cell recovery rate was 98%.

比較例2 直径が7.2μm、長きが40 rtnnから7011
1Eノボリアミド繊維(ナイロン−66)f、直径が6
6市、長さ7’O+II+llOカラムに6.67f均
一に詰めた白血球除去フィルター装置(嵩密度0.09
3グ/7)を作成した。300 rdの採血バッグ2個
からそれぞれ落差800 mraの位置に、上記の白血
球除去フィルターをつけ、さらに800 +、′Irn
下方に1tの輸液バッグ金つけて、処理した血液全貯蔵
する回収バッグとし、その間をそれぞれ内径3111J
外径5市のチューブで連結した処理装置を作成した。こ
の処理装置の採血バッグ2個に、B型の健康人のへマド
クリット42係の新鮮ACD−A液添加血液全血250
 mlずつを入れ、落差を利用した自然落下法により、
室@25Cで1バツグずつ順番に白血球除去処理を行っ
た。
Comparative Example 2 Diameter is 7.2 μm, length is 40 rtnn to 7011
1E nobolyamide fiber (nylon-66) f, diameter 6
Leukocyte removal filter device (bulk density 0.09
3/7) was created. Attach the above leukocyte removal filters at a height of 800 mra from two 300 rd blood collection bags, and then add 800 +, 'Irn.
A 1 ton infusion bag is attached at the bottom to serve as a collection bag for storing all the processed blood, and each bag has an inner diameter of 3111 J.
A processing device was created that was connected by tubes with an outer diameter of 5 mm. Two blood collection bags of this processing device contain 250 whole blood of a healthy person with blood type B, Hemadcrit 42, fresh ACD-A liquid-added blood.
ml each, and by the natural fall method using the drop,
Leukocyte removal treatment was performed one bag at a time in room @25C.

つぎに、生理食塩水80rn1.−i自然落下法により
、この白血球除去フィルター装置に流し、フィルター内
の赤血球を回収した。
Next, add 80rn1 of physiological saline. -i By the gravity fall method, the red blood cells were poured into this leukocyte removal filter device and the red blood cells in the filter were collected.

その結果、この新鮮血液500−の処理時間は1時間2
4分45秒であり、処理速度にして5゜9−7分でちっ
た。また、白血球除去率は95.1チ、赤血球回収率は
94%であった。
As a result, the processing time for this fresh blood 500- is 1 hour 2
The processing time was 4 minutes and 45 seconds, and the processing speed was 5°9-7 minutes. Furthermore, the leukocyte removal rate was 95.1%, and the red blood cell recovery rate was 94%.

実施例2によれば、本発明の白血球除去フィルターは、
従来の白血球除去フィルターと比較して約12倍の高速
処理であり、白血球除去率が良く、赤血球回収率も従来
法と同程度の優秀な性能であった。
According to Example 2, the leukocyte removal filter of the present invention includes:
Compared to conventional leukocyte removal filters, the processing speed was about 12 times faster, the leukocyte removal rate was good, and the red blood cell recovery rate was also excellent, comparable to the conventional method.

実施例6 直径0.8μmのポリアミド繊維(ナイロン−66)を
溶融ブロー法で作成した高密度J169/7の繊維塊が
繊維の互いのもつれによってその位置に固定されている
不織布を、直径100111111、厚さ2Tnmの円
柱状に切断し、有効内径90mm、厚さ6 TnrAの
カラム中に固定した。600−の採血ノ(ノブ21固か
らそれぞれ落差8001111flの位置に、上記の白
血球除去フィルター装置をつけ、さらに8001111
1下方に1tの輸液バッグをつけて、処理した液分貯蔵
する回収バッグとし、その間をそれぞれ内径3Tnm、
外径5 +11111のチューブで連結した処理装置を
作成した。この処理装置の採血バッグ2個に、A型の健
康人のヘマトクリツ)4591の新鮮CPD液添加血液
全血250 mlずつを入れ、落差を利用した自然落下
法によシ、室温25Cにて1バツグずつ順番に白血球除
去処理を行った。
Example 6 A nonwoven fabric with a diameter of 100111111, in which a high-density J169/7 fiber mass made of polyamide fibers (nylon-66) with a diameter of 0.8 μm by a melt-blowing method was fixed in position by the mutual entanglement of the fibers. It was cut into a cylindrical shape with a thickness of 2 Tnm and fixed in a column with an effective inner diameter of 90 mm and a thickness of 6 TnrA. Attach the above-mentioned leukocyte removal filter device to the blood sampling tube of 600-1 (at a height of 8001111fl from the knob 21), and then
A 1 ton infusion bag is attached to the lower part of the bag, which serves as a collection bag for storing the treated liquid.
A processing device was created which was connected with tubes having an outer diameter of 5 + 11111 mm. Put 250 ml of fresh whole blood of a healthy person with blood type A (hematocrit) 4591 into two blood collection bags of this processing device, and collect one bag at a room temperature of 25C using the gravity drop method using a drop. Leukocyte removal treatment was performed on each sample in turn.

つぎに、生理食塩水5〇−全自然落下法により、この白
血球除去フィルター装置に流し、フィルター内の赤血球
全回収した。
Next, physiological saline was poured into this leukocyte removal filter device by a 50-degree gravity drop method, and all the red blood cells in the filter were recovered.

その結果、この新鮮血液500 mlの処理時間は6分
29秒であり、処理速度にして77、ml1分という高
速流であった。また、白血球除去率は99.9係であシ
、赤血球回収率は98%であった。
As a result, the processing time for 500 ml of fresh blood was 6 minutes and 29 seconds, which was a processing speed of 77 and a high flow rate of 1 minute per ml. Furthermore, the leukocyte removal rate was 99.9, and the red blood cell recovery rate was 98%.

比較例3 直径が5.2μm1長さが40諦から70 TnTnの
アクリロニ) l)ル系合成繊維を、直径が80市、長
さ40 mNOカラムに187全均一に詰めた白血球除
去フィルター装置(嵩密度0.0901 /crd )
を作成した。300rnlの採血バッグ2個からそれぞ
れ落差800mmの位置に、上記の白血球除去フィルタ
ーをつけ、窟らにa o o mvl下方に1tの輸液
バッグをつけて、処理した血液を貯蔵する回収バッグと
し、その開音それぞれ内径5mm、外径s mmのチュ
ーブで連結した処理装置を作成した。この処理装置の採
血バッグ2個に、A型の健康人のへマドクリット45乃
の新鮮CPDl添加血液全血250meずつ全入れ、落
差を利用した自然落下法により、室125Cで1バツグ
ずつ順番に白血球除去処理を行った。
Comparative Example 3 Leukocyte removal filter device (bulky Density 0.0901/crd)
It was created. Attach the leukocyte removal filter described above at a height of 800 mm from two 300 rnl blood collection bags, and attach a 1 ton infusion bag to the lower part of the tube to serve as a collection bag for storing the processed blood. A treatment device was prepared in which each tube was connected with a tube having an inner diameter of 5 mm and an outer diameter of s mm. Fill two blood collection bags of this processing device with 250 me of fresh CPDl-added whole blood of 45 hemadrits of type A healthy people, and collect leukocytes one bag at a time in chamber 125C using the natural fall method using a drop. A removal process was performed.

つぎに、生理食塩水210 mlを自然落下法により、
この白血球除去フィルター装置に流し、フィルター内の
赤血球を回収した。
Next, add 210 ml of physiological saline using the gravity drop method.
The blood was passed through this leukocyte removal filter device, and the red blood cells inside the filter were collected.

その結果、この新鮮血液500−の処理時間は19分1
4秒であり、処理速度にして2 ’6 ml 7分でめ
った。しかし、白血球除去率は68.4%、赤血球回収
率は91.3 %であった。
As a result, the processing time for 500 liters of fresh blood was 19 minutes.
The processing time was 4 seconds, and the processing speed was 2'6 ml in 7 minutes. However, the leukocyte removal rate was 68.4% and the red blood cell recovery rate was 91.3%.

実施例6によれば、本発明の白血球除去フィルターは7
8−7分という高速処理であった。また、従来法で高速
処理を試みたが、処理速度は26m7!/分と速くした
ところ、白血球除去率が低下した。したがって、従来法
では処理速度を早くするには限度があり、本発明のよう
な高速処理はできない。
According to Example 6, the leukocyte removal filter of the present invention has 7
It was a fast process of 8-7 minutes. I also tried high-speed processing using the conventional method, but the processing speed was only 26m7! When the speed was increased to /min, the leukocyte removal rate decreased. Therefore, in the conventional method, there is a limit to how high the processing speed can be increased, and high-speed processing as in the present invention cannot be achieved.

実施例4 直径2.8μmのポリエステル111維を浴融ブロー法
にて作成した嵩簡度0.28 ? /7の不織布を製造
する際、溶融ブロ一時250Cで2秒間乾熱処理し、繊
維の互いにもつり、あった接点を熱固着した不織布を作
成した。この不織布を、直径160m3厚さa nun
の円柱状に切断し、有効内径150711m。
Example 4 Polyester 111 fibers with a diameter of 2.8 μm were made by the bath melt blowing method.The bulkiness was 0.28? When producing the nonwoven fabric No. 7, a dry heat treatment was performed at 250 C for 2 seconds during the melt blowing process to create a nonwoven fabric in which the fibers were tied together and the contact points were thermally fixed. This non-woven fabric has a diameter of 160 m3 and a thickness of a nun.
Cut into a cylindrical shape with an effective inner diameter of 150,711 m.

j学さ12 Il+rnのカラム中に固定した。300
−の採血バッグ2個からそれぞれ落差800朋の位置に
、上記の白血球除去フィルター全つけ、きらに800m
m下方に1tの輸液バッグをつけて、処理した液を貯蔵
する回収バッグとし、その間をそれぞれ内径31111
11、外径51+1I11のチューブで連結した処理装
置を作成した。この処理装置の採血バッグ21固に、0
型の健康人のへマドクリソトロ4チのCPD液添加血液
濃厚液(遠心分離法により1部血漿を除去したもの)の
1日4Cで保存したものを200meずつ入才し、落差
を利用した自然落下法により、4Cの冷蔵庫より取り出
し、ただちに、室温10Cにて1バツグずつ順番に白血
球除去処理を行った。
It was fixed in a column of 12 Il+rn. 300
- Attach all of the leukocyte removal filters mentioned above to the two blood collection bags at a height of 800 m, respectively.
A 1 ton infusion bag is attached below m to serve as a collection bag for storing the treated solution, and the inner diameter of the bag between them is 31111 mm.
11. A processing device connected with tubes having an outer diameter of 51+1I11 was created. The blood collection bag 21 of this processing device has 0
Concentrated blood containing CPD solution (from which a portion of the plasma has been removed by centrifugation) of a healthy human body type was stored at 4C for 200 days per day, and then allowed to fall naturally using a drop. According to the method, each bag was taken out from a 4C refrigerator and immediately subjected to leukocyte removal treatment in order at a room temperature of 10C.

つぎに、生理食塩水220 mlを自然落下法により、
この白血球除去フィルターに流し、フィルター内の赤血
球を回収した。
Next, add 220 ml of physiological saline using the gravity drop method.
It was passed through this leukocyte removal filter, and the red blood cells inside the filter were collected.

その結果、この新鮮面400ばの処理時間は6分27秒
であり、□処理速度にして62me1分という高流速で
あった。−!た、白血球除去率は98.9係であり、赤
血球の回収率は91%であった。
As a result, the processing time for 400 units of fresh surface was 6 minutes and 27 seconds, and the processing speed was as high as 62me1 minute. -! The leukocyte removal rate was 98.9, and the red blood cell recovery rate was 91%.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明の白血球除去フィルターによるフィルタ
ー装置の一実施態様を示す正面図、第2図は同縦断側面
図、第3図は別の実施態様を示す 1正面図、第4凶は
同縦断側面図、第5図は本発明の白血球除去フィルター
によるフィルター装置の使用態様?示す説明図である。 1・・・・・・フィルター装置本体 2,2′・・・・
・・丸盆状枠体3・・・・・・リング部材 4,4′・
・・・・・突条 5,5′・・・・・・メツシュ状支持
材 6・・・・・・フィルター 7・・・・・・血液流
入管 8・・・・・・血液流出管 9,9′・・・・・
・・くツキラグ10 、10’・・・・・・丸盆状枠体
 11 、11’・・・・・・メツシュ状支持材 12
・・・・・・フィルター 16・・・・・・血液流入管
14・・・・・・血欣Mシ出1i7 15 、15’・
・・・・・ノくツキラグ16・−・・・・採血バッグ 
17・・・・・・回路 18・・・・・・フィルクー装
置 19・・・・・・回路 20・・・・・・回収バッ
グ 21・・・・・・生理食塩水バッグ 22・・・・
・・回路 26・・・・・・回収ノ(ラグ24・・・・
・・調整バルブ 第1圓 第2図 ↓ −l 第3図 0 第40 第5図
FIG. 1 is a front view showing one embodiment of a filter device using a leukocyte removal filter of the present invention, FIG. 2 is a vertical side view of the same, and FIG. 3 is a front view of another embodiment. The vertical side view, FIG. 5, shows how the filter device using the leukocyte removal filter of the present invention is used. FIG. 1... Filter device body 2, 2'...
... Round tray-shaped frame body 3 ... Ring member 4, 4'.
... Protrusions 5, 5' ... Mesh-like support material 6 ... Filter 7 ... Blood inflow pipe 8 ... Blood outflow pipe 9 ,9'...
...Kutsuki rug 10, 10'...Round tray-shaped frame 11, 11'...Mesh-shaped support material 12
... Filter 16 ... Blood inflow pipe 14 ... Blood sample M output 1i7 15 , 15'.
・・・・・・Nokutsukirag 16・・・・Blood collection bag
17...Circuit 18...Fill-coup device 19...Circuit 20...Collection bag 21...Physiological saline bag 22...
...Circuit 26...Recovery (lag 24...
...Adjustment valve 1st circle 2nd figure ↓ -l Figure 3 0 40 Figure 5

Claims (2)

【特許請求の範囲】[Claims] (1)繊維の直径が3μm未満で、嵩密度が0.15f
/crA全超え0.50 f/cd以下の不織布からな
る白血球除去フィルター。
(1) The fiber diameter is less than 3μm and the bulk density is 0.15f
A leukocyte removal filter made of a non-woven fabric with a total exceedance of /crA of 0.50 f/cd or less.
(2) 不織布が、繊維の互いのもつれによシその位置
に固定されているものである特許請求の範囲第1項記載
の白血球除去フィルター。
(2) The leukocyte removal filter according to claim 1, wherein the nonwoven fabric is fixed in position by mutual tangles of fibers.
JP59048173A 1984-03-15 1984-03-15 Leucocyte removal filter Granted JPS60193468A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP59048173A JPS60193468A (en) 1984-03-15 1984-03-15 Leucocyte removal filter
US06711667 US4701267B1 (en) 1984-03-15 1985-03-14 Method for removing leukocytes
EP85102975A EP0155003B1 (en) 1984-03-15 1985-03-14 Filtering unit for removing leukocytes
DE8585102975T DE3578502D1 (en) 1984-03-15 1985-03-14 FILTER UNIT FOR SEPARATING LEUKOCYTES.
JP3135364A JPH0651063B2 (en) 1984-03-15 1991-05-13 How to selectively remove white blood cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59048173A JPS60193468A (en) 1984-03-15 1984-03-15 Leucocyte removal filter
JP3135364A JPH0651063B2 (en) 1984-03-15 1991-05-13 How to selectively remove white blood cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP3135364A Division JPH0651063B2 (en) 1984-03-15 1991-05-13 How to selectively remove white blood cells

Publications (2)

Publication Number Publication Date
JPS60193468A true JPS60193468A (en) 1985-10-01
JPH0213587B2 JPH0213587B2 (en) 1990-04-04

Family

ID=26388401

Family Applications (2)

Application Number Title Priority Date Filing Date
JP59048173A Granted JPS60193468A (en) 1984-03-15 1984-03-15 Leucocyte removal filter
JP3135364A Expired - Lifetime JPH0651063B2 (en) 1984-03-15 1991-05-13 How to selectively remove white blood cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP3135364A Expired - Lifetime JPH0651063B2 (en) 1984-03-15 1991-05-13 How to selectively remove white blood cells

Country Status (1)

Country Link
JP (2) JPS60193468A (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63311962A (en) * 1987-06-15 1988-12-20 Terumo Corp Instrument for separating blood components
JPH01224016A (en) * 1988-03-03 1989-09-07 Terumo Corp Liquid filtration device
JPH01320064A (en) * 1988-06-23 1989-12-26 Asahi Medical Co Ltd Blood component separating system
JPH01320065A (en) * 1988-06-23 1989-12-26 Asahi Medical Co Ltd Blood component separating system
JPH03188872A (en) * 1989-12-20 1991-08-16 Taiichiro Iwakura Method for deactivating aids virus
US5478470A (en) * 1991-08-22 1995-12-26 Asahi Medical Co., Ltd. Filter material for selectively removing leukocytes
JPH0817813B1 (en) * 1986-10-06 1996-02-28
JP2001347161A (en) * 2000-06-06 2001-12-18 Toray Ind Inc Adsorbent and column for extracorporeal circulation
JP2002113097A (en) * 2000-05-23 2002-04-16 Toray Ind Inc Adsorbent and in vitro circulation column
US6977044B1 (en) 1999-11-01 2005-12-20 Asahi Medical Co., Ltd. Filter for selectively removing leukocytes
WO2008026667A1 (en) 2006-08-31 2008-03-06 Toray Industries, Inc. Adsorption carrier containing composite fiber
JPWO2005120600A1 (en) * 2004-06-09 2008-04-03 旭化成メディカル株式会社 Leukocyte removal method and filter used in the method
WO2008038785A1 (en) 2006-09-29 2008-04-03 Toray Industries, Inc. Cell-adsorbing column
WO2009084613A1 (en) 2007-12-27 2009-07-09 Toray Industries, Inc. Fiber construct for treating biological components
WO2010064538A1 (en) * 2008-12-03 2010-06-10 テルモ株式会社 Blood bag system and blood processing method
WO2012057185A1 (en) 2010-10-27 2012-05-03 東レ株式会社 Carrier for blood component adsorption and blood component adsorption column
JP2012120458A (en) * 2010-12-06 2012-06-28 Kaneka Corp Cell separator
US8496833B2 (en) 2005-01-06 2013-07-30 Asahi Kasei Medical Co., Ltd. Leukocyte removal method
US8584869B2 (en) 2005-03-31 2013-11-19 Toray Industries, Inc. Absorbent and column for extracorporeal circulation
JP2017127347A (en) * 2016-01-18 2017-07-27 フォースエンジニアリング株式会社 Medical filter device
WO2019049962A1 (en) 2017-09-08 2019-03-14 東レ株式会社 Immunosuppressive leukocyte adsorption material and adsorption column
WO2020183951A1 (en) * 2019-03-12 2020-09-17 テルモ株式会社 Filtration device
US10814051B2 (en) 2015-06-17 2020-10-27 Asahi Kasei Medical Co., Ltd. Filter element for blood processing filter and blood processing filter

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010037978A1 (en) * 1999-04-20 2001-11-08 Daryl R. Calhoun Filter assembly having a flexible housing and method of making same
ATE246028T1 (en) * 1995-12-26 2003-08-15 Asahi Medical Co FILTRATION AGENT FOR REMOVAL OF LEUKOCYTES
US6699388B1 (en) * 1998-05-13 2004-03-02 Asahi Medical Co., Ltd. Filter device and method for processing blood
CA2464351A1 (en) * 2001-10-16 2003-04-24 Asahi Medical Co., Ltd. Method for selectively removing virus and leukocytes, removing material and removing apparatus
CN105813663B (en) 2013-12-13 2017-09-22 旭化成医疗株式会社 The method for removing the filtering material of white blood cell and removing white blood cell

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54119012A (en) * 1978-03-06 1979-09-14 Asahi Chem Ind Co Ltd Filter for leucocyte separation, and method for separating leucocyte using the same
JPS5631737A (en) * 1979-08-22 1981-03-31 Baxter Travenol Lab Blood filter for white corpuscle
JPS5653616A (en) * 1979-10-09 1981-05-13 Asahi Chem Ind Co Ltd Separating method of leukocyte, its separator and its separation filter
JPS5721009U (en) * 1980-07-08 1982-02-03

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5521535A (en) * 1978-07-31 1980-02-15 Nippon Steel Corp Producing method of highly tough and tensile low alloy steel

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54119012A (en) * 1978-03-06 1979-09-14 Asahi Chem Ind Co Ltd Filter for leucocyte separation, and method for separating leucocyte using the same
JPS5631737A (en) * 1979-08-22 1981-03-31 Baxter Travenol Lab Blood filter for white corpuscle
JPS5653616A (en) * 1979-10-09 1981-05-13 Asahi Chem Ind Co Ltd Separating method of leukocyte, its separator and its separation filter
JPS5721009U (en) * 1980-07-08 1982-02-03

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0817813B1 (en) * 1986-10-06 1996-02-28
JPS63311962A (en) * 1987-06-15 1988-12-20 Terumo Corp Instrument for separating blood components
JPH01224016A (en) * 1988-03-03 1989-09-07 Terumo Corp Liquid filtration device
JPH01320064A (en) * 1988-06-23 1989-12-26 Asahi Medical Co Ltd Blood component separating system
JPH01320065A (en) * 1988-06-23 1989-12-26 Asahi Medical Co Ltd Blood component separating system
JPH03188872A (en) * 1989-12-20 1991-08-16 Taiichiro Iwakura Method for deactivating aids virus
US5478470A (en) * 1991-08-22 1995-12-26 Asahi Medical Co., Ltd. Filter material for selectively removing leukocytes
US5665233A (en) * 1991-08-22 1997-09-09 Asahi Medical Co., Ltd. Filter apparatus for selectively removing leukocytes
US6977044B1 (en) 1999-11-01 2005-12-20 Asahi Medical Co., Ltd. Filter for selectively removing leukocytes
JP2002113097A (en) * 2000-05-23 2002-04-16 Toray Ind Inc Adsorbent and in vitro circulation column
JP2001347161A (en) * 2000-06-06 2001-12-18 Toray Ind Inc Adsorbent and column for extracorporeal circulation
JP4505950B2 (en) * 2000-06-06 2010-07-21 東レ株式会社 Adsorbent and extracorporeal circulation column
US8900462B2 (en) 2004-06-09 2014-12-02 Asahi Kasei Medical Co., Ltd Method for removing leukocyte and filter for use therein
JPWO2005120600A1 (en) * 2004-06-09 2008-04-03 旭化成メディカル株式会社 Leukocyte removal method and filter used in the method
KR100845063B1 (en) 2004-06-09 2008-07-09 아사히 가세이 메디컬 가부시키가이샤 Method for removing leukocyte and filter for use therein
JP4854083B2 (en) * 2004-06-09 2012-01-11 旭化成メディカル株式会社 Leukocyte removal method and filter used in the method
US8496833B2 (en) 2005-01-06 2013-07-30 Asahi Kasei Medical Co., Ltd. Leukocyte removal method
US8584869B2 (en) 2005-03-31 2013-11-19 Toray Industries, Inc. Absorbent and column for extracorporeal circulation
KR101340932B1 (en) * 2006-08-31 2013-12-13 도레이 카부시키가이샤 Adsorption carrier containing composite fiber
WO2008026667A1 (en) 2006-08-31 2008-03-06 Toray Industries, Inc. Adsorption carrier containing composite fiber
WO2008038785A1 (en) 2006-09-29 2008-04-03 Toray Industries, Inc. Cell-adsorbing column
WO2009084613A1 (en) 2007-12-27 2009-07-09 Toray Industries, Inc. Fiber construct for treating biological components
CN102215885A (en) * 2008-12-03 2011-10-12 泰尔茂株式会社 Blood bag system and blood processing method
WO2010064538A1 (en) * 2008-12-03 2010-06-10 テルモ株式会社 Blood bag system and blood processing method
US8439889B2 (en) 2008-12-03 2013-05-14 Terumo Kabushiki Kaisha Blood bag system and blood treating method
JP2013138920A (en) * 2008-12-03 2013-07-18 Terumo Corp Blood bag system
JP5281655B2 (en) * 2008-12-03 2013-09-04 テルモ株式会社 Blood bag system and blood processing method
US9802178B2 (en) 2010-10-27 2017-10-31 Toray Industries, Inc. Carrier for blood component adsorption and blood component adsorption column
WO2012057185A1 (en) 2010-10-27 2012-05-03 東レ株式会社 Carrier for blood component adsorption and blood component adsorption column
JP2012120458A (en) * 2010-12-06 2012-06-28 Kaneka Corp Cell separator
US10814051B2 (en) 2015-06-17 2020-10-27 Asahi Kasei Medical Co., Ltd. Filter element for blood processing filter and blood processing filter
JP2017127347A (en) * 2016-01-18 2017-07-27 フォースエンジニアリング株式会社 Medical filter device
WO2019049962A1 (en) 2017-09-08 2019-03-14 東レ株式会社 Immunosuppressive leukocyte adsorption material and adsorption column
KR20200051578A (en) 2017-09-08 2020-05-13 도레이 카부시키가이샤 Immunosuppressive leukocyte adsorption material and adsorption column
WO2020183951A1 (en) * 2019-03-12 2020-09-17 テルモ株式会社 Filtration device

Also Published As

Publication number Publication date
JPH0663131A (en) 1994-03-08
JPH0651063B2 (en) 1994-07-06
JPH0213587B2 (en) 1990-04-04

Similar Documents

Publication Publication Date Title
JPS60193468A (en) Leucocyte removal filter
US4701267A (en) Method for removing leukocytes
EP1238694B1 (en) Device and method for depletion of the leukocyte content of blood components
US4923620A (en) Device for depletion of the leukocyte content of blood and blood components
JP2523938B2 (en) Platelet purification filter
US4976861A (en) Method for determining the wetting characteristic of a porous medium
JPH0327317A (en) Device and method to reduce the leucocyte content of blood and blood components
JPH0213588B2 (en)
JPH0534337A (en) Filter for separating leucocyte
EP0365676A1 (en) Blood component separator
JPH04329965A (en) Selective removal method of leukocyte
JPS61128979A (en) Blood treatment apparatus
JP3208132B2 (en) Blood component separation method
JP2559615B2 (en) Leukocyte capture filter for concentrated red blood cells
JP3088764B2 (en) Blood component separation method
JPS6012578Y2 (en) Fiber entanglement separation material
JP3635654B2 (en) Blood component collection device
JPH0659305B2 (en) Blood component separation method
JPS60194959A (en) Modified blood component removing filter
JP3157519B2 (en) Blood component separation system
AU624095B2 (en) Depletion of leukocyte from blood
JPS5854126B2 (en) Leukocyte separation material
GB2250690A (en) Blood filters
JP2555722C (en)
IL106893A (en) Device and method for separating substance(s) from a fluid to be administered to a patient

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term